The committee based its decision on data showing the subcutaneous formulation of Opdivo was not inferior to the intravenous formulation.

Sarepta Therapeutics announced that a patient with Duchenne muscular dystrophy who received Elevidys (delandistrogene moxeparvovec-rokl) died following treatment.

Compared to the IV infusion of the blockbuster cancer drug Keytruda, subcutaneous Keytruda was able to reduce the time patients spent in the chemotherapy chair.

Eli Lilly (LLY) stock in focus as an expert panel of the EU drug regulator declines to endorse its Alzheimer's drug Kisunla.

Canada announced that Health Canada has expanded the marketing authorization for HyQvia for chronic inflammatory demyelinating ...

One of the most crucial aspects of psychedelic therapy is the process of making meaning from psychedelic experiences and ...

BRIDGEWATER, NJ / ACCESS Newswire / March 24, 2025 / Tharimmune, Inc. (Nasdaq:THAR) ("Tharimmune" or the "Company"), a ...

Educational videos discussing a general overview of the purpose of nerve blocks, how they are placed, and how to take care of yourself after having one. For any other questions at any time, please ...

The Food and Drug Administration warned a California cannabis company on Monday that its injectable hemp CBD could be posing “serious harm” to public health, telling the company that its product is ...

Doctors suggest taking a combination or "cocktail" of at least two of them. This is called antiretroviral therapy (ART). Your doctor will tell you specifically how to take your medications.

Background Intravenous iron therapy with ferric derisomaltose (FDI) has been shown to improve outcomes in patients with heart failure with reduced ejection fraction (HFrEF) and iron deficiency.